At its April meeting, the National Academy of Sciences will honor Dr. Edward C. Taylor, the A. Barton Hepburn Professor of Organic Chemistry Emeitus at Princeton University in New Jersey, with the Chemistry in Service to Society award. Dr. Taylor’s contributions to heterocyclic chemistry lead to the development of pemetrexed (brand name Alimta), the first and only FDA-approved treatment for mesothelioma. Pemetrexed works by blocking substances in the body that help cancer cells to reproduce. Approved for the treatment of mesothelioma and small-cell lung cancer, pemetrexed is also being tested in numerous clinical trials for other cancer types.
As advocates for victims of mesothelioma and their families, the Pennsylvania and New Jersey asbestos attorneys at Brookman, Rosenberg, Brown & Sandler recognize the importance of Dr. Taylor’s work and accomplishments. We applaud Dr. Taylor and his contributions to the ongoing research for the development of mesothelioma treatments and hopefully one day soon a mesothelioma cure. Only through the dedication and diligence of physicians and researchers such as Dr. Taylor can the deadly disease and its devastating effects be eradicated.
Mesothelioma and lung cancer both affect the respiratory system, yet they differ in origin, development, and available legal remedies. Although…
The School District of Philadelphia is currently facing criminal charges for allegedly failing to meet legal requirements regarding the inspection,…
Asbestos was once praised as a miracle material for its strength, heat resistance, and insulating properties. However, the hidden danger…
Brookman, Rosenberg, Brown & Sandler is proud to announce that Partners Howell K. Rosenberg, Esq. and Laurence H. Brown, Esq.…
Asbestos exposure has long been linked to serious health conditions such as mesothelioma, lung cancer, and asbestosis. While many people…
Mesothelioma is a rare and incurable form of cancer that is caused by exposure to asbestos. The costs associated with…